BRCA2 Germline Mutations in Familial Pancreatic Carcinoma

作者: S. A. Hahn , B. Greenhalf , I. Ellis , M. Sina-Frey , H. Rieder

DOI: 10.1093/JNCI/95.3.214

关键词:

摘要: Background Although as many 10% of pancreatic cancer cases may have an inherited component, familial has not been linked to defects in any specific gene. Some studies shown that families with germline mutations the breast susceptibility gene BRCA2 increased risk and ovarian cancers, well a modestly cancer. To study these relationships more detail, we examined whether are associated Methods We identified 26 European which at least two first-degree relatives had histologically confirmed diagnosis ductal adenocarcinoma. sequenced genomic DNA isolated from peripheral blood lymphocytes obtained participating family members identify BRCA2. Results Three (12%, exact 95% confidence interval [CI] = 2% 30%) carried frameshift predicted result truncated protein. Two additional harbored previously designated unclassified variants Thus, 19% (exact CI 7% 39%) our either mutation or variant None met criteria for Conclusions Our data support important role subpopulation analysis should be included molecular genetic testing counseling strategies affected adenocarcinoma pancreas.

参考文章(40)
Michael Goggins, Ralph H. Hruban, Scott E. Kern, BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. American Journal of Pathology. ,vol. 156, pp. 1767- 1771 ,(2000) , 10.1016/S0002-9440(10)65047-X
Suzanne E. Applebaum, Jeffrey A. Kant, David C. Whitcomb, Ian H. Ellis, Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases. Medical Clinics of North America. ,vol. 84, pp. 575- 588 ,(2000) , 10.1016/S0025-7125(05)70241-8
Henry T. Lynch, Thomas C. Smyrk, Patrice Watson, Stephen J. Lanspa, Jane F. Lynch, Patrick M. Lynch, R.Jennifer Cavalieri, C.Richard Boland, Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review Gastroenterology. ,vol. 104, pp. 1535- 1549 ,(1993) , 10.1016/0016-5085(93)90368-M
Akseli Hemminki, David Markie, Ian Tomlinson, Egle Avizienyte, Stina Roth, Anu Loukola, Graham Bignell, William Warren, Maria Aminoff, Pia Höglund, Heikki Järvinen, Paula Kristo, Katarina Pelin, Maaret Ridanpää, Reijo Salovaara, Tumi Toro, Walter Bodmer, Sylviane Olschwang, Anne S Olsen, Michael R Stratton, Albert De La Chapelle, Lauri A Aaltonen, None, A serine/threonine kinase gene defective in Peutz–Jeghers syndrome Nature. ,vol. 391, pp. 184- 187 ,(1998) , 10.1038/34432
Ralph H. Hruban, Mieke Schutte, Charles J. Yeo, Henry T. Lynch, Scott E. Kern, Craig L. Weinstein, Charles E. Jackson, Michael Goggins, Gloria M. Petersen, Jia Lu, Christopher A. Moskaluk, Germline BRCA2 Gene Mutations in Patients with Apparently Sporadic Pancreatic Carcinomas Cancer Research. ,vol. 56, pp. 5360- 5364 ,(1996)
C La Vecchia, E Negri, B D'Avanzo, E Fernandez, S Franceschi, Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 3, pp. 209- 212 ,(1994)
Karen White, Karsten R. Held, Bernhard H.F. Weber, A BRCA2 germ-line mutation in familial pancreatic carcinoma. International Journal of Cancer. ,vol. 91, pp. 742- 744 ,(2001) , 10.1002/1097-0215(200002)9999:9999<::AID-IJC1116>3.0.CO;2-L
H Tulinius, G H Olafsdottir, H Sigvaldason, L Tryggvadottir, K Bjarnadottir, Neoplastic diseases in families of breast cancer patients. Journal of Medical Genetics. ,vol. 31, pp. 618- 621 ,(1994) , 10.1136/JMG.31.8.618
D.M Parkin, F.I Bray, S.S Devesa, Cancer burden in the year 2000. The global picture. European Journal of Cancer. ,vol. 37, pp. 4- 66 ,(2001) , 10.1016/S0959-8049(01)00267-2
W Bergman, P Watson, J de Jong, HT Lynch, RM Fusaro, Systemic cancer and the FAMMM syndrome British Journal of Cancer. ,vol. 61, pp. 932- 936 ,(1990) , 10.1038/BJC.1990.209